Analog Devices Surpasses Q3 Earnings Expectations
Analog Devices reports impressive Q3 earnings and revenue, surpassing forecasts and projecting a positive Q4 outlook.
- Latest
- Trending
Analog Devices reports impressive Q3 earnings and revenue, surpassing forecasts and projecting a positive Q4 outlook.
The IEA reports a continued decline in Chinese oil demand amid weakened industrial activity and a struggling economy.
Roivant reports strong clinical progress, with significant Phase 3 study completions, revenue growth, and financial strength.
Recursion Pharmaceuticals acquires Exscientia to enhance AI drug discovery, potentially saving millions in drug development costs.
Exscientia merges into Recursion to form a $850 million AI drug discovery powerhouse, focusing on oncology and rare diseases.
Roche is evaluating options for its $1.9 billion investment in Flatiron Health, potentially including divestment.
Explore conflicting analyst opinions on Alnylam's HELIOS-B data, contrasting efficacy views for vutrisiran in addressing ATTR-CM treatments.
"Western companies bolster rare earths supply chain, reduce China's dominance, focus on vital materials for EVs, wind turbines, and drones."
"Western Rare Earths Supply Chain Diversifies: Companies expand global production to reduce dependence on China for essential permanent magnets."
Roche's Hemlibra braces for fierce competition from Novo Nordisk's mim8, as analysts give mixed ratings and forecasts on Roche's strategic ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.